Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10231)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 27, 2015 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kalogeridi MA, Zygogianni A, Kyrgias G, Kouvaris J, Chatziioannou S, Kelekis N, Kouloulias V. Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review. World J Hepatol 2015; 7(1): 101-112 [PMID: 25625001 DOI: 10.4254/wjh.v7.i1.101] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i1/101.htm |
| Number | Citing Articles |
| 1 |
Yi-Hsiu Chung, Ching-Fang Yu, Shao-Chieh Chiu, Han Chiu, Shin-Ting Hsu, Ching-Rong Wu, Chung-Lin Yang, Ji-Hong Hong, Tzu-Chen Yen, Fang-Hsin Chen. Diffusion-weighted MRI and 18F-FDG PET correlation with immunity in early radiotherapy response in BNL hepatocellular carcinoma mouse model: timeline validation. European Journal of Nuclear Medicine and Molecular Imaging 2019; 46(8): 1733 doi: 10.1007/s00259-019-04318-3
|
| 2 |
Natally Horvat, Ana I. de Oliveira, Brunna Clemente de Oliveira, Jose A. B. Araujo-Filho, Maria El Homsi, Ahmed Elsakka, Raazi Bajwa, Guilherme L. P. Martins, Khaled M. Elsayes, Marcos R. Menezes. Local-Regional Treatment of Hepatocellular Carcinoma: A Primer for Radiologists. RadioGraphics 2022; 42(6): 1670 doi: 10.1148/rg.220022
|
| 3 |
Keihan Kookli, Kosar Torfi Soleimani, Eman Fathy Amr, Hadi Mohammed Ehymayed, Rahman S. Zabibah, Shakhnoza B. Daminova, Mohamed J. Saadh, Fahad Alsaikhan, Mohaned Adil, Mohammed Shnain Ali, Saghar Mohtashami, Reza Akhavan-Sigari. Role of microRNA-146a in cancer development by regulating apoptosis. Pathology - Research and Practice 2024; 254: 155050 doi: 10.1016/j.prp.2023.155050
|
| 4 |
Wuping Yang, Lijian Shao, Sihong Zhu, Huan Li, Xinxin Zhang, Congcong Ding, Xincheng Wu, Rui Xu, Mengzhen Yue, Jiahui Tang, Bohai Kuang, Guangqin Fan, Qingxian Zhu, Huihong Zeng. Transient Inhibition of mTORC1 Signaling Ameliorates Irradiation-Induced Liver Damage. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.00228
|
| 5 |
Jing-Hua Wu, Jia-Pei Guo, Jun Shi, Hui Wang, Lei-Lei Li, Bin Guo, Dian-Xing Liu, Qing Cao, Zhi-Yong Yuan. CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(13): 2308-2317 doi: 10.3748/wjg.v23.i13.2308
|
| 6 |
Demet Alici-Karaca, Bahriye Akay, Arzu Yay, Pinar Suna, O. Ufuk Nalbantoglu, Dervis Karaboga, Alper Basturk, Esra Balcioglu, Munevver Baran. A new lightweight convolutional neural network for radiation-induced liver disease classification. Biomedical Signal Processing and Control 2022; 73: 103463 doi: 10.1016/j.bspc.2021.103463
|
| 7 |
Berardino De Bari, Thomas Breuneval, Michele Zeverino, Sarah Godin, Letizia Deantonio, Christine Geldhof, Jean Bourhis, Nicklaus Schaefer, Raphaël Moeckli, John Prior, Mahmut Ozsahin, Qinghui Zhang. Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study. PLOS ONE 2018; 13(10): e0204013 doi: 10.1371/journal.pone.0204013
|
| 8 |
Amreen Shakur, Aileen O’Shea, Mukesh G. Harisinghani. Atlas of Lymph Node Anatomy. 2021; : 55 doi: 10.1007/978-3-030-80899-0_3
|
| 9 |
Michael J. LaRiviere, Patricia Mae G. Santos, Christine E. Hill-Kayser, James M. Metz. Proton Therapy. Hematology/Oncology Clinics of North America 2019; 33(6): 989 doi: 10.1016/j.hoc.2019.08.006
|
| 10 |
Jeong Il Yu, Hee Chul Park. Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis. World Journal of Gastroenterology 2016; 22(30): 6851-6863 doi: 10.3748/wjg.v22.i30.6851
|
| 11 |
金连 李. Advances in Diagnosis and Treatment of Hepatocellular Carcinoma. Advances in Clinical Medicine 2024; 14(07): 738 doi: 10.12677/acm.2024.1472075
|
| 12 |
Zong-Sian Cai, Ming-Jen Chen, Tzu-Yin Tang, Ching-Wei Chang. Duodenum perforated after combination with sorafenib and radiotherapy for retroperitoneal lymph node metastasis of hepatocellular carcinoma. Journal of the Formosan Medical Association 2020; 119(3): 760 doi: 10.1016/j.jfma.2019.10.009
|
| 13 |
Jason K. Wong, Howard J. Lim, Vincent C. Tam, Kelly W. Burak, Laura A. Dawson, Prosanto Chaudhury, Robert J. Abraham, Brandon M. Meyers, Gonzalo Sapisochin, David Valenti, Setareh Samimi, Ravi Ramjeesingh, Amol Mujoomdar, Ilidio Martins, Elijah Dixon, Maja Segedi, David M. Liu. Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada. Cancer Treatment Reviews 2023; 115: 102526 doi: 10.1016/j.ctrv.2023.102526
|
| 14 |
S Erridge, P H Pucher, S R Markar, G Malietzis, T Athanasiou, A Darzi, M H Sodergren, L R Jiao. Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma. British Journal of Surgery 2017; 104(11): 1433 doi: 10.1002/bjs.10597
|
| 15 |
Cathal O’Leary, Mary Mahler, Michael C. Soulen. Curative-Intent Therapies in Localized Hepatocellular Carcinoma. Current Treatment Options in Oncology 2020; 21(4) doi: 10.1007/s11864-020-0725-3
|
| 16 |
Jeong Il Yu, Hee Chul Park, Dongryul Oh, Jae Myoung Noh, Sang Hoon Jung, Hye Yeong Kim, Sung Wook Shin, Sung Ki Cho, Dong Hyun Sinn, Yong-Han Paik, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo. Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial. International Journal of Hyperthermia 2016; 32(3): 331 doi: 10.3109/02656736.2016.1144895
|
| 17 |
Amal R Ebrahim, Mohamed El-Mesery, Amro El-Karef, Laila A. Eissa. Vitamin D potentiates anti-tumor activity of 5-fluorouracil via modulating caspase-3 and TGF-β1 expression in hepatocellular carcinoma-induced in rats. Canadian Journal of Physiology and Pharmacology 2018; 96(12): 1218 doi: 10.1139/cjpp-2018-0445
|
| 18 |
Mutlay Sayan, Nikhil Yegya-Raman, Stephanie H. Greco, Bin Gui, Andrew Zhang, Anupama Chundury, Miral S. Grandhi, Howard S. Hochster, Timothy J. Kennedy, Russell C. Langan, Usha Malhotra, Vinod K. Rustgi, Mihir M. Shah, Kristen R. Spencer, Darren R. Carpizo, John L. Nosher, Salma K. Jabbour. Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00345
|
| 19 |
Pankaj Nepal, Claire Crowley, Mukesh Harisinghani. Comprehensive Guide to Hepatitis Advances. 2023; : 61 doi: 10.1016/B978-0-323-98368-6.00018-5
|
| 20 |
Yan Pan, Cuiping Zhou, Dexiao Yuan, Jianghong Zhang, Chunlin Shao. Radiation Exposure Promotes Hepatocarcinoma Cell Invasion through Epithelial Mesenchymal Transition Mediated by H2S/CSE Pathway. Radiation Research 2016; 185(1): 96 doi: 10.1667/RR14177.1
|
| 21 |
S P Susheela, S Revannasiddaiah, A S Basavalingaiah, I Madabhavi. Painless lump over the forehead which turned painful: an unusual presentation of hepatocellular carcinoma. BJR|case reports 2015; 1(2): 20150033 doi: 10.1259/bjrcr.20150033
|
| 22 |
Tetsuya Ikemoto, Mitsuo Shimada, Shinichiro Yamada. Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation. Hepatology Research 2017; 47(1): 23 doi: 10.1111/hepr.12705
|
| 23 |
Changhoon Choi, Arang Son, Ga-Haeng Lee, Sung-Won Shin, Sohee Park, Sang Hee Ahn, Yoonsun Chung, Jeong Il Yu, Hee Chul Park, Yi-Hsien Hsieh. Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction. PLOS ONE 2019; 14(6): e0218049 doi: 10.1371/journal.pone.0218049
|
| 24 |
Jiarui Yang, Hao Liang, Kunpeng Hu, Zhiyong Xiong, Mingbo Cao, Zhaozhong Zhong, Zhicheng Yao, Meihai Deng. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01790-6
|
| 25 |
Alejandro Forner, María Reig, María Varela, Marta Burrel, Jaime Feliu, Javier Briceño, Javier Sastre, Luis Martí-Bonmati, Josep María Llovet, José Ignacio Bilbao, Bruno Sangro, Fernando Pardo, Carmen Ayuso, Concepció Bru, Josep Tabernero, Jordi Bruix. Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH. Medicina Clínica (English Edition) 2016; 146(11): 511.e1 doi: 10.1016/j.medcle.2016.07.013
|
| 26 |
Erqi L. Pollom, Yushen Qian, Julie L. Koenig, Albert C. Koong, Daniel T. Chang. Radiation Therapy for Liver Tumors. 2017; : 179 doi: 10.1007/978-3-319-54531-8_14
|
| 27 |
Jia-Yun Chen, Da-Quan Wang, Xiao-Dong Zhang, Qi Fu, Xue-Na Yan, Kuo Men, Jian-Rong Dai, Nan Bi. Sparing lung tissue with virtual block method in VMAT planning for locally advanced non-small cell lung cancer. Nuclear Science and Techniques 2022; 33(4) doi: 10.1007/s41365-022-01033-x
|
| 28 |
Jing Luo, Zhong-Zhou Si, Ting Li, Jie-Qun Li, Zhong-Qiang Zhang, Guang-Shun Chen, Hai-Zhi Qi, Hong-Liang Yao. MicroRNA-146a-5p enhances radiosensitivity in hepatocellular carcinoma through replication protein A3-induced activation of the DNA repair pathway. American Journal of Physiology-Cell Physiology 2019; 316(3): C299 doi: 10.1152/ajpcell.00189.2018
|
| 29 |
Amene Saghazadeh, Mahsa Keshavarz-Fathi, Farnaz Delavari, Nima Rezaei. Cancer Immunology. 2021; : 587 doi: 10.1007/978-3-030-50287-4_30
|
| 30 |
Alejandro Forner, María Reig, Jordi Bruix. Hepatocellular carcinoma. The Lancet 2018; 391(10127): 1301 doi: 10.1016/S0140-6736(18)30010-2
|
| 31 |
Huimei Zhang, Na Chang, Tiantian Han, Shaodi Ma, Guangbo Qu, Haixia Liu, Chenyu Sun, Ce Cheng, Qin Zhou, Yehuan Sun. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for hepatocellular carcinoma: a meta-analysis. Future Oncology 2021; 17(30): 4027 doi: 10.2217/fon-2021-0263
|
| 32 |
Jae Min Jung, Seong Han Kim, V. H. Giang Phan, Thavasyappan Thambi, Doo Sung Lee. Therapeutic effects of boronate ester cross-linked injectable hydrogels for the treatment of hepatocellular carcinoma. Biomaterials Science 2021; 9(21): 7275 doi: 10.1039/D1BM00881A
|
| 33 |
Rosanna H Yeung, Tobias R Chapman, Stephen R Bowen, Smith Apisarnthanarax. Proton beam therapy for hepatocellular carcinoma. Expert Review of Anticancer Therapy 2017; 17(10): 911 doi: 10.1080/14737140.2017.1368392
|
| 34 |
Samuel Shyllon, Scott Penfold, Ray Dalfsen, Elsebe Kirkness, Ben Hug, Pejman Rowshanfarzad, Peter Devlin, Colin Tang, Hien Le, Peter Gorayski, Garry Grogan, Rachel Kearvell, Martin A Ebert. Dosimetric comparison of proton therapy and CyberKnife in stereotactic body radiation therapy for liver cancers. Physical and Engineering Sciences in Medicine 2024; 47(3): 1203 doi: 10.1007/s13246-024-01440-x
|
| 35 |
Jian Shen, Junnian Hao, Yini Chen, Hairong Liu, Jianrong Wu, Bing Hu, Yan Wang, Yuanyi Zheng, Xiaojun Cai. Neutrophil-mediated clinical nanodrug for treatment of residual tumor after focused ultrasound ablation. Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-01087-w
|
| 36 |
Andrea Spallanzani, Giulia Orsi, Kalliopi Andrikou, Fabio Gelsomino, Margherita Rimini, Laura Riggi, Stefano Cascinu. Lenvatinib as a therapy for unresectable hepatocellular carcinoma. Expert Review of Anticancer Therapy 2018; 18(11): 1069 doi: 10.1080/14737140.2018.1524297
|
| 37 |
David Prince, Ken Liu, Weiqi Xu, Minjiang Chen, Jin-Yu Sun, Xiao-Jie Lu, Jiansong Ji. Management of patients with intermediate stage hepatocellular carcinoma. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920970840
|
| 38 |
Yan Zhou, Ping He, Xuhua Xie, Changyu Sun. Knockdown of SUMO1P3 represses tumor growth and invasion and enhances radiosensitivity in hepatocellular carcinoma. Molecular and Cellular Biochemistry 2019; 450(1-2): 125 doi: 10.1007/s11010-018-3379-8
|
| 39 |
Kuniaki Fukuda, Toshiyuki Okumura, Masato Abei, Nobuyoshi Fukumitsu, Kazunori Ishige, Masashi Mizumoto, Naoyuki Hasegawa, Haruko Numajiri, Kayoko Ohnishi, Hitoshi Ishikawa, Koji Tsuboi, Hideyuki Sakurai, Ichinosuke Hyodo. Long‐term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma. Cancer Science 2017; 108(3): 497 doi: 10.1111/cas.13145
|
| 40 |
Shufang Xiang, Juan Li, Mei Zhang. TGF-β1 inhibitor enhances the therapeutic effect of microwave ablation on hepatocellular carcinoma. International Journal of Hyperthermia 2024; 41(1) doi: 10.1080/02656736.2024.2359496
|
| 41 |
Nourihan S. Farrag, Abeer M. Amin. Preliminary evaluation of the radiotherapeutic efficacy of 131I-atorvastatin in rats with hepatocellular carcinoma. Nuclear Science and Techniques 2020; 31(11) doi: 10.1007/s41365-020-00819-1
|
| 42 |
Xiaoxue Wu, Mengchao Wei, Yong Chen, Zhenwei Peng. Surgery or external beam radiation for solitary small hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2023; 19(Suppl 1): S166 doi: 10.4103/jcrt.JCRT_1604_20
|
| 43 |
Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park. Current role of proton beam therapy in patients with hepatocellular carcinoma. International Journal of Gastrointestinal Intervention 2021; 10(4): 175 doi: 10.18528/ijgii210043
|
| 44 |
Takeshi Okuda, Nakamasa Hayashi, Masamichi Takahashi, Takeo Uzuka, Yoshiko Okita, Ryohei Otani, Toshiyuki Fujinaka, Mitsugu Fujita, Amami Kato, Yoshitaka Narita, Yoko Nakasu. Clinical outcomes of brain metastases from hepatocellular carcinoma: a multicenter retrospective study and a literature review. International Journal of Clinical Oncology 2018; 23(6): 1095 doi: 10.1007/s10147-018-1312-5
|
| 45 |
Mohanned Alnammi, Jeremy Wortman, Jaclyn Therrien, Jalil Afnan. MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review. Abdominal Radiology 2022; 47(7): 2299 doi: 10.1007/s00261-022-03526-0
|
| 46 |
Maria Marsico, Tommaso Gabbani, Sarah Lunardi, Andrea Galli, Maria Rosa Biagini, Vito Annese. Percutaneous ultrasound-guided fiducial marker placement for liver cancer robotic stereotactic radio-surgery treatment: A comparative analysis of three types of markers and needles. Arab Journal of Gastroenterology 2017; 18(2): 83 doi: 10.1016/j.ajg.2017.05.007
|
| 47 |
Markus Mandl, Maria- Katharina Lieberum, Juergen Dunst, Reinhard Depping. The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment. Radiation Oncology 2015; 10(1) doi: 10.1186/s13014-015-0539-9
|
| 48 |
Yifeng Cui, Shuhang Liang, Shugeng Zhang, Congyi Zhang, Yunzheng Zhao, Dehai Wu, Jiabei Wang, Ruipeng Song, Jizhou Wang, Dalong Yin, Yao Liu, Shangha Pan, Xirui Liu, Yan Wang, Jihua Han, Fanzheng Meng, Bo Zhang, Hongrui Guo, Zhaoyang Lu, Lianxin Liu. ABCA8 is regulated by miR-374b-5p and inhibits proliferation and metastasis of hepatocellular carcinoma through the ERK/ZEB1 pathway. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01591-1
|
| 49 |
Cuauhtémoc de la Peña, María F. Gonzalez, César González, Joel M. Salazar, Benjamín Cruz. Stereotactic body radiation therapy for liver metastases: Clinical outcomes and literature review. Reports of Practical Oncology & Radiotherapy 2020; 25(4): 637 doi: 10.1016/j.rpor.2020.04.021
|
| 50 |
Gouling Zhan, Honghua Peng, Lehong Zhou, Long Jin, Xueyi Xie, Yu He, Xuan Wang, Zhangyan Du, Peiguo Cao. A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1070396
|
| 51 |
Kwei-Yan Liu, Li-Ting Wang, Shih-Hsien Hsu, Shen-Nien Wang. Homeobox Genes and Hepatocellular Carcinoma. Cancers 2019; 11(5): 621 doi: 10.3390/cancers11050621
|
| 52 |
Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, Giovanni Galati, Giuseppe Lombardi, GianCarlo Mazza, Luca Marzi, Carlo Saitta, Jean-Charles Nault, Rodolfo Sacco. The Calm Before the Storm: A Report from the International Liver Cancer Association Congress 2015 – Part 1. Future Oncology 2016; 12(3): 281 doi: 10.2217/fon.15.323
|
| 53 |
Yu‐chen Hou, Chao Zhang, Zi‐jie Zhang, Lei Xia, Ke‐qiang Rao, Li‐hong Gu, Yi‐chi Wu, Zi‐cheng Lv, Hao‐xiang Wu, Xiao‐lei Zuo, Fan Li, Hao Feng, Qiang Xia. Aggregation‐Induced Emission (AIE) and Magnetic Resonance Imaging Characteristics for Targeted and Image‐Guided siRNA Therapy of Hepatocellular Carcinoma. Advanced Healthcare Materials 2022; 11(17) doi: 10.1002/adhm.202200579
|
| 54 |
Alejandro Forner, María Reig, María Varela, Marta Burrel, Jaime Feliu, Javier Briceño, Javier Sastre, Luis Martí-Bonmati, Josep María Llovet, José Ignacio Bilbao, Bruno Sangro, Fernando Pardo, Carmen Ayuso, Concepció Bru, Josep Tabernero, Jordi Bruix. Diagnóstico y tratamiento del carcinoma hepatocelular. Actualización del documento de consenso de la AEEH, SEOM, SERAM, SERVEI y SETH. Medicina Clínica 2016; 146(11): 511.e1 doi: 10.1016/j.medcli.2016.01.028
|
| 55 |
Qiuyan Lin, Xiaoquan Huang, Canmei Zhong, Tiancheng Luo, Xiaoqing Zeng, Shiyao Chen. Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity‐matched analysis of Surveillance, Epidemiology, and End Results database. Cancer Medicine 2019; 8(2): 515 doi: 10.1002/cam4.1937
|
| 56 |
Sarah Ama Baidoo, Emmanuel Konadu Sarkodie, Kofi Oti Boakye-Yiadom, Samuel Kesse. Nanomedicinal delivery systems for intelligent treatment of hepatocellular carcinoma. Journal of Drug Delivery Science and Technology 2019; 53: 101152 doi: 10.1016/j.jddst.2019.101152
|
| 57 |
Pierre Rabinel, Damien Dousse, Fabrice Muscari, Bertrand Suc. Management of liver cancer. The Surgeon's point of view. Reports of Practical Oncology & Radiotherapy 2017; 22(2): 176 doi: 10.1016/j.rpor.2017.02.001
|
| 58 |
David Stephen Prince, Glen Schlaphoff, Scott Anthony Davison, Ya Ruth Huo, Hao Xiang, Michael Vinchill Chan, Alice Unah Lee, Cynthuja Thailakanathan, Hazem Jebeili, Christopher Rogan, Ahmed Al‐Omary, Sidhartha Gupta, Ian Lockart, Neha Tiwari, McCawley Clark‐Dickson, James William Hillhouse, Robyn Laube, Jeff Chang, Vi Nguyen, Mark Danta, Robert Cheng, Simone Irene Strasser, Amany Zekry, Miriam Tania Levy, Christine Chan, Ken Liu. Selective internal radiation therapy for hepatocellular carcinoma: A 15‐year multicenter Australian cohort study. Journal of Gastroenterology and Hepatology 2022; 37(11): 2173 doi: 10.1111/jgh.15986
|
| 59 |
Jason Liu, Colton Ladbury, Yi-Jen Chen. Interventional Oncology. 2023; : 1 doi: 10.1007/978-3-030-51192-0_85-1
|
| 60 |
Shingo Toyama, Yoshiyuki Shioyama, Hiroaki Suefuji, Makoto Shinoto, Keiji Matsumoto, Kotaro Terashima, Masaaki Hidaka, Susumu Eguchi, Kuniko Abe, Hiroyuki Irie, Yuichiro Eguchi. A case of the cirrhotic patient performed living donor liver transplantation after carbon-ion radiotherapy for hepatocellular carcinoma. International Cancer Conference Journal 2018; 7(2): 65 doi: 10.1007/s13691-018-0322-5
|
| 61 |
Nicholas G. Berger, Michael N. Tanious, Abdulrahman Y. Hammad, John T. Miura, Harveshp Mogal, Callisia N. Clarke, Kathleen K. Christians, Susan Tsai, T. Clark Gamblin. External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database. Journal of Surgical Oncology 2017; 116(3): 307 doi: 10.1002/jso.24661
|
| 62 |
Ashwaq Alolyan, Kanan Alshammari, Mohammad Arabi, Ahmed Alshehri, Hamad Alsuhaibani, Fahad Ibnshamsah, Abdullah Alsharm, Mervat Mahrous, Adnan Al Zanbagi, Mazen Hassanain, Shouki Bazarbashi. Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia. Journal of Hepatocellular Carcinoma 2024; : 349 doi: 10.2147/JHC.S442842
|
| 63 |
Xi Yang, Ling Gao, Qing Guo, Yongjiang Li, Yue Ma, Ju Yang, Changyang Gong, Cheng Yi. Nanomaterials for radiotherapeutics-based multimodal synergistic cancer therapy. Nano Research 2020; 13(10): 2579 doi: 10.1007/s12274-020-2722-z
|
| 64 |
Bing Han, Chuan Li, Hao Meng, Fernando Gomes Romeiro, Andrea Mancuso, Zhirui Zhou, Giovanni Battista Levi Sandri, Ying Xu, Tao Han, Lei Han, Lichun Shao, Xingshun Qi. Efficacy and safety of external-beam radiation therapy for hepatocellular carcinoma: An overview of current evidence according to the different target population. BioScience Trends 2019; 13(1): 10 doi: 10.5582/bst.2018.01261
|
| 65 |
Chao-Yue Ku, Xue-Ke Yang, Li-Jing Xi, Rui-Zhe Wang, Bin-Bin Wu, Man Dai, Li Liu, Zhi-Guang Ping. Competing risks analysis of external versus internal radiation in patients with hepatocellular carcinoma after controlling for immortal time bias. Journal of Cancer Research and Clinical Oncology 2023; 149(12): 9927 doi: 10.1007/s00432-023-04915-8
|
| 66 |
Sally Elnawasany, Yusuf A. Haggag, Shahinaz M. Shalaby, Nema A. Soliman, Amira A. EL Saadany, Marwa A. A. Ibrahim, Farid Badria. Anti-cancer effect of nano-encapsulated boswellic acids, curcumin and naringenin against HepG-2 cell line. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-04096-4
|
| 67 |
Lizhi Xiao, Enhua Xiao. Blood oxygen level–dependent functional magnetic resonance imaging can evaluate the efficiency of transcatheter arterial chemoembolization in hepatocellular carcinoma. Journal of Interventional Medicine 2019; 2(1): 5 doi: 10.1016/j.jimed.2019.05.002
|
| 68 |
Young-Hsiang Lin, Shih-Kai Hung, Wen-Yen Chiou, Moon-Sing Lee, Bing-Jie Shen, Liang-Cheng Chen, Dai-Wei Liu, Wei-Ta Tsai, Po-Hao Lin, Yi-Ting Shih, Feng-Chun Hsu, Shiang-Jiun Tsai, Michael W.Y. Chan, Hon-Yi Lin. Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma. Medicine 2016; 95(34): e4717 doi: 10.1097/MD.0000000000004717
|
| 69 |
Pengcheng Hu, Dengfeng Cheng, Tao Huang, Anna B. Banizs, Jie Xiao, Guobing Liu, Quan Chen, Yuenan Wang, Jiang He, Hongcheng Shi. Evaluation of Novel 64Cu-Labeled Theranostic Gadolinium-Based Nanoprobes in HepG2 Tumor-Bearing Nude Mice. Nanoscale Research Letters 2017; 12(1) doi: 10.1186/s11671-017-2292-5
|
| 70 |
Christopher D. Woodrell, Nathan E. Goldstein, Jaison R. Moreno, Thomas D. Schiano, Myron E. Schwartz, Melissa M. Garrido. Inpatient Specialty-Level Palliative Care Is Delivered Late in the Course of Hepatocellular Carcinoma and Associated With Lower Hazard of Hospital Readmission. Journal of Pain and Symptom Management 2021; 61(5): 940 doi: 10.1016/j.jpainsymman.2020.09.040
|
| 71 |
Gyu Sang Yoo, Jeong Il Yu, Sungkoo Cho, Sang Hoon Jung, Youngyih Han, Seyjoon Park, Yoonjin Oh, Boram Lee, Hee Chul Park, Do Hoon Lim, Moon Seok Choi, Hojeong Won. Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma. Radiotherapy and Oncology 2020; 146: 187 doi: 10.1016/j.radonc.2020.02.019
|
| 72 |
Hanzhang Zhu, Ke Ge, Jun Lu, Changku Jia. Growth inhibitor of human hepatic carcinoma HepG2 cells by evodiamine is associated with downregulation of PRAME. Naunyn-Schmiedeberg's Archives of Pharmacology 2019; 392(12): 1551 doi: 10.1007/s00210-019-01701-7
|
| 73 |
Changhoon Choi, Ga Haeng Lee, Arang Son, Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park. Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells. Cells 2021; 10(3): 554 doi: 10.3390/cells10030554
|
| 74 |
Jin‐Yu Sun, Tailang Yin, Xiao‐Yu Zhang, Xiao‐Jie Lu. Therapeutic advances for patients with intermediate hepatocellular carcinoma. Journal of Cellular Physiology 2019; 234(8): 12116 doi: 10.1002/jcp.28019
|
| 75 |
Sabine Gerum, Christian Heinz, Claus Belka, Franziska Walter, Philipp Paprottka, Enrico N. De Toni, Falk Roeder. Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease. Radiation Oncology 2018; 13(1) doi: 10.1186/s13014-018-1048-4
|
| 76 |
Sabine Gerum, Alexandra D Jensen, Falk Roeder. Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review. World Journal of Gastrointestinal Oncology 2019; 11(5): 367-376 doi: 10.4251/wjgo.v11.i5.367
|
| 77 |
Yutaka Endo, Kazunari Sasaki, Zorays Moazzam, Selamawit Woldesenbet, Jason Yang, Henrique Araujo Lima, Laura Alaimo, Muhammad Musaab Munir, Chanza F. Shaikh, Austin Schenk, Minoru Kitago, Timothy M. Pawlik. The Impact of a Liver Transplant Program on the Outcomes of Hepatocellular Carcinoma. Annals of Surgery 2023; 278(2): 230 doi: 10.1097/SLA.0000000000005849
|
| 78 |
Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives. World Journal of Gastroenterology 2018; 24(28): 3090-3100 doi: 10.3748/wjg.v24.i28.3090
|
| 79 |
Neha Bakshi, Vineeta Chand, Rishu Sangal, Rajan Duggal. Radiation Induced Liver Injury: Collateral Damage Radiologically Simulating Interval Metastasis in Carcinoma Esophagus; a Diagnostic Dilemma Resolved Through Liver Biopsy. International Journal of Surgical Pathology 2022; 30(8): 945 doi: 10.1177/10668969221095181
|
| 80 |
Camille Hardy-Abeloos, Stanislav Lazarev, Meng Ru, Edward Kim, Aaron Fischman, Erin Moshier, Kenneth Rosenzweig, Michael Buckstein. Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization. International Journal of Radiation Oncology*Biology*Physics 2019; 105(5): 968 doi: 10.1016/j.ijrobp.2019.09.006
|
| 81 |
Xiuhong Liu, Shuang Wang, Xianghua Guo, Feili Wei, Jiming Yin, Yunjin Zang, Ning Li, Dexi Chen. Exogenous p53 and ASPP2 expression enhances rAdV-TK/GCV-induced death in hepatocellular carcinoma cells lacking functional p53. Oncotarget 2016; 7(14): 18896 doi: 10.18632/oncotarget.7749
|
| 82 |
Nontoxic In Vivo Clearable Nanoparticle Clusters for Theranostic Applications. ACS Biomaterials Science & Engineering 2022; 8(5): 2053 doi: 10.1021/acsbiomaterials.1c01579
|
| 83 |
Sabine Gerum, Christian Heinz, Claus Belka, Franziska Walter, Philipp Marius Paprottka, Enrico N De Toni, Falk Roeder. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting. Strahlentherapie und Onkologie 2020; 196(4): 334 doi: 10.1007/s00066-019-01540-8
|
| 84 |
Yixian Guo, Jiejun Chen, Yunfei Zhang, Yinglong Guo, Mengmeng Jiang, Yongming Dai, Xiuzhong Yao. Differentiating Cytokeratin 19 expression of hepatocellular carcinoma by using multi-b-value diffusion-weighted MR imaging with mono-exponential, stretched exponential, intravoxel incoherent motion, diffusion kurtosis imaging and fractional order calculus models. European Journal of Radiology 2022; 150: 110237 doi: 10.1016/j.ejrad.2022.110237
|
| 85 |
Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy?. International Journal of Radiation Biology 2022; 98(10): 1495 doi: 10.1080/09553002.2022.2055800
|
| 86 |
Yueh-Shan Weng, I-Tsang Chiang, Jai-Jen Tsai, Yu-Chang Liu, Fei-Ting Hsu. Lenvatinib Synergistically Promotes Radiation Therapy in Hepatocellular Carcinoma by Inhibiting Src/STAT3/NF-κB-Mediated Epithelial–Mesenchymal Transition and Metastasis. International Journal of Radiation Oncology*Biology*Physics 2023; 115(3): 719 doi: 10.1016/j.ijrobp.2022.09.060
|
| 87 |
Aimen Farooq, Zohaib Ahmed, James Wert, Anum Jalil, James Yu, Vadim Zaytsev, Sarfraz Ahmad. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 259 doi: 10.1016/B978-0-323-99283-1.00013-6
|
| 88 |
Katerina Mastrocostas, Hyun-Jung Jang, Sandra Fischer, Laura A. Dawson, Pablo Munoz-Schuffenegger, Gonzalo Sapisochin, Tae Kyoung Kim. Imaging post-stereotactic body radiation therapy responses for hepatocellular carcinoma: typical imaging patterns and pitfalls. Abdominal Radiology 2019; 44(5): 1795 doi: 10.1007/s00261-019-01901-y
|
| 89 |
John Chun-Hao Chen, Hui-Yen Chuang, Fei-Ting Hsu, Yi-Chen Chen, Yi-Chun Chien, Jeng-Jong Hwang. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model. Oncotarget 2016; 7(51): 85450 doi: 10.18632/oncotarget.13398
|
| 90 |
Shigeyuki Takamatsu, Kazuto Kozaka, Satoshi Kobayashi, Norihide Yoneda, Kotaro Yoshida, Dai Inoue, Azusa Kitao, Takahiro Ogi, Tetsuya Minami, Wataru Kouda, Tomoyasu Kumano, Nobukazu Fuwa, Osamu Matsui, Toshifumi Gabata. Pathology and images of radiation-induced hepatitis: a review article. Japanese Journal of Radiology 2018; 36(4): 241 doi: 10.1007/s11604-018-0728-1
|
| 91 |
Abdulsalam Alhalmi, Sarwar Beg, Kanchan Kohli, Md. Waris, Tanuja Singh. Nanotechnology Based Approach for Hepatocellular Carcinoma Targeting. Current Drug Targets 2021; 22(7): 779 doi: 10.2174/1389450121999201209194524
|
| 92 |
Maria Marsico, Tommaso Gabbani, Lorenzo Livi, Maria Rosa Biagini, Andrea Galli. Therapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study. World Journal of Hepatology 2016; 8(17): 731-738 doi: 10.4254/wjh.v8.i17.731
|
| 93 |
Oluwaseun Adebayo Bamodu, Hang-Lung Chang, Jiann-Ruey Ong, Wei-Hwa Lee, Chi-Tai Yeh, Jo-Ting Tsai. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma. Cells 2020; 9(3): 746 doi: 10.3390/cells9030746
|
| 94 |
Hyeong-Geug Kim, Seong-Soon Jang, Jin-Seok Lee, Hyo-Seon Kim, Chang-Gue Son. Panax ginseng Meyer prevents radiation-induced liver injury via modulation of oxidative stress and apoptosis. Journal of Ginseng Research 2017; 41(2): 159 doi: 10.1016/j.jgr.2016.02.006
|
| 95 |
Perla Chami, Youssef Diab, Danny N. Khalil, Hassan Azhari, William R. Jarnagin, Ghassan K. Abou-Alfa, James J. Harding, Joseph Hajj, Jennifer Ma, Maria El Homsi, Marsha Reyngold, Christopher Crane, Carla Hajj. Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(23): 16773 doi: 10.3390/ijms242316773
|
| 96 |
Jing Cai, Qiang Xiong, Xiaoliu Jiang, Shan Zhou, Tiande Liu. RNF6 facilitates metastasis and radioresistance in hepatocellular carcinoma through ubiquitination of FoxA1. Experimental Cell Research 2019; 374(1): 152 doi: 10.1016/j.yexcr.2018.11.019
|
| 97 |
Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park, Dongho Hyun, Woo Kyoung Jeong, Ho Yeong Lim, Moon Seok Choi, Sang Yun Ha. Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?. Cancers 2020; 12(9): 2395 doi: 10.3390/cancers12092395
|
| 98 |
Cathal O'Leary, Michael C. Soulen, Susan Shamimi-Noori. Interventional Oncology Approach to Hepatic Metastases. Seminars in Interventional Radiology 2020; 37(05): 484 doi: 10.1055/s-0040-1719189
|
| 99 |
Yu-huan Bai, Xiao-jing Yun, Yan Xue, Ting Zhou, Xin Sun, Yan-jing Gao. A novel oncolytic adenovirus inhibits hepatocellular carcinoma growth. Journal of Zhejiang University-SCIENCE B 2019; 20(12): 1003 doi: 10.1631/jzus.B1900089
|
| 100 |
Mina Răileanu, Mihai Straticiuc, Decebal-Alexandru Iancu, Radu-Florin Andrei, Mihai Radu, Mihaela Bacalum. Proton irradiation induced reactive oxygen species promote morphological and functional changes in HepG2 cells. Journal of Structural Biology 2022; 214(4): 107919 doi: 10.1016/j.jsb.2022.107919
|
| 101 |
Alireza Tojjari, James Yu, Anwaar Saeed. Immunotherapy and Radiation Therapy Combinatorial Approaches in Hepatocellular Carcinoma. Cancers 2024; 16(5): 1058 doi: 10.3390/cancers16051058
|
| 102 |
Ryosuke Nakano, Masahiro Ohira, Tsuyoshi Kobayashi, Yuki Imaoka, Hiroaki Mashima, Megumi Yamaguchi, Naruhiko Honmyo, Sho Okimoto, Michinori Hamaoka, Seiichi Shimizu, Shintaro Kuroda, Hiroyuki Tahara, Kentaro Ide, Hideki Ohdan. Independent risk factors that predict bile leakage after hepatectomy for hepatocellular carcinoma: Cohort study. International Journal of Surgery 2018; 57: 1 doi: 10.1016/j.ijsu.2018.07.005
|
| 103 |
Pengcheng Hu, Zhequan Fu, Guobing Liu, Hui Tan, Jie Xiao, Hongcheng Shi, Dengfeng Cheng. Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular Carcinoma. Frontiers in Bioengineering and Biotechnology 2019; 7 doi: 10.3389/fbioe.2019.00368
|
| 104 |
Edson J. Comparetti, Paula M. P. Lins, João Quitiba, Valtencir Zucolotto. Cancer cell membrane‐derived nanoparticles block the expression of immune checkpoint proteins on cancer cells and coordinate modulatory activity on immunosuppressive macrophages. Journal of Biomedical Materials Research Part A 2022; 110(8): 1499 doi: 10.1002/jbm.a.37387
|
| 105 |
Minpeng Li, Jun He, Meng Pan, Yuan Yu, Zhuang Pan, Bin Xu, Jiye Zhu. Iodine-125 implantation plus transarterial chemoembolization for the treatment of hepatocellular carcinoma of 3–5cm: A propensity score matching study. Digestive and Liver Disease 2016; 48(9): 1082 doi: 10.1016/j.dld.2016.06.007
|
| 106 |
Feng‑Tao Yi, Qi‑Ping Lu. Mucin 1 promotes radioresistance in hepatocellular carcinoma cells through activation of JAK2/STAT3 signaling. Oncology Letters 2017; doi: 10.3892/ol.2017.7119
|
| 107 |
Laura Callan, Haddis Razeghi, Natalie Grindrod, Stewart Gaede, Eugene Wong, David Tan, Jason Vickress, John Patrick, Michael Lock. Prognostic Index for Liver Radiation (PILiR). Current Oncology 2024; 31(10): 5862 doi: 10.3390/curroncol31100436
|
| 108 |
Changhoon Choi, Gyu Sang Yoo, Won Kyung Cho, Hee Chul Park. Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(20): 2416-2429 doi: 10.3748/wjg.v25.i20.2416
|
| 109 |
Sumit Roy, Vancha Harish, Sharfuddin Mohd, Sachin Kumar Singh. Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment. Advanced Therapeutics 2024; doi: 10.1002/adtp.202400126
|
| 110 |
Xiaopeng Yan, Yudong Qiu. Impact of current staging systems on treatment strategy for HBV-related hepatocellular carcinoma. Cancer Letters 2016; 379(2): 220 doi: 10.1016/j.canlet.2015.08.009
|
| 111 |
Ryosuke Nakano, Masahiro Ohira, Tsuyoshi Kobayashi, Kentaro Ide, Hiroyuki Tahara, Shintaro Kuroda, Seiichi Shimizu, Tomoki Kimura, Yasushi Nagata, Hiroshi Aikata, Kazuaki Chayama, Hideki Ohdan. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution. Surgery 2018; 164(2): 219 doi: 10.1016/j.surg.2018.03.006
|